Showing results (81-90 of 103) with videos related to

Sort By:
Pageof 11
Hepatology (Baltimore, Md.)|June 16, 2011
The use of liver biopsy evaluation in discrimination of idiopathic autoimmune hepatitis versus drug-induced liver injuryAyako Suzuki, Elizabeth M Brunt, David E Kleiner, et al.
Hepatology (Baltimore, Md.)|October 19, 2011
Biochemical and immunologic effects of rituximab in patients with primary biliary cirrhosis and an incomplete response to ursodeoxycholic acidMasanobu Tsuda, Yuki Moritoki, Zhe-Xiong Lian, et al.
Gastroenterology|May 9, 2018
Corticosteroids Reduce Risk of Death Within 28 Days for Patients With Severe Alcoholic Hepatitis, Compared With Pentoxifylline or Placebo-a Meta-analysis of Individual Data From Controlled TrialsAlexandre Louvet, Mark R Thursz, Dong Joon Kim, et al.
Hepatology (Baltimore, Md.)|October 31, 2009
B-cell depletion with anti-CD20 ameliorates autoimmune cholangitis but exacerbates colitis in transforming growth factor-beta receptor II dominant negative miceYuki Moritoki, Zhe-Xiong Lian, Keith Lindor, et al.
Alimentary Pharmacology & Therapeutics|November 26, 2019
Consensus guidelines: best practices for detection, assessment and management of suspected acute drug-induced liver injury occurring during clinical trials in adults with chronic cholestatic liver diseaseMelissa Palmer, Arie Regev, Keith Lindor, et al.
British Journal of Haematology|April 26, 2017
Treatment of chronic hepatitis C with direct-acting antivirals in patients with β-thalassaemia major and advanced liver diseaseEmmanouil Sinakos, Dimitrios Kountouras, John Koskinas, et al.
Hepatology (Baltimore, Md.)|January 29, 2011
B cell depletion therapy exacerbates murine primary biliary cirrhosisAmy Dhirapong, Ana Lleo, Guo-Xiang Yang, et al.
Hepatology (Baltimore, Md.)|November 25, 2015
Ustekinumab for patients with primary biliary cholangitis who have an inadequate response to ursodeoxycholic acid: A proof-of-concept studyGideon M Hirschfield, M Eric Gershwin, Richard Strauss, et al.
Gastroenterology|January 29, 2008
Immunoglobulin G4-associated cholangitis: clinical profile and response to therapyAmaar Ghazale, Suresh T Chari, Lizhi Zhang, et al.
Hepatology (Baltimore, Md.)|March 30, 2007
The NAFLD fibrosis score: a noninvasive system that identifies liver fibrosis in patients with NAFLDPaul Angulo, Jason M Hui, Giulio Marchesini, et al.
Pageof 11